Back

Prediction of individualized lifetime benefit from cardiovascular risk-reducing interventions in apparently healthy people

European Heart Journal

1 August 2019
Organised by: Logo
Read full article
ESC Journals PREVENTIVE CARDIOLOGY Risk Factors and Prevention

Abstract

Abstract

You may be interested in
thumbnail
Congress Presentation
Predicted lifetime therapy benefit guided treatment effectively reduces residual cardiovascular risk in patients with symptomatic atherosclerotic disease
29 August 2020
thumbnail
Congress Presentation
The prognostic value of ECG parameters for 20-year cardiovascular risk and incremental improvement of SCORE2-based prediction modelling: the ATTICA cohort study (2002–2022)
30 August 2026
thumbnail
Congress Presentation
Coronary risk reduction intervention for siblings and offspring of patients with premature coronary heart disease: the criso project.
3 April 2025
thumbnail
Congress Presentation
Validation of the LIFE-CVD2 model for lifetime cardiovascular risk prediction in cancer survivors
5 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources